Extension Agreement between Cyclacel Pharmaceuticals, Inc. and Paul McBarron, effective as of January 1, 2023

EX-10.2 3 tm2233702d1_ex10-2.htm EXHIBIT 10.2

Exhibit 10.2

CYCLACEL PHARMACEUTICALS, INC.

200 Connell Drive, Suite 1500

Berkeley Heights, NJ 07922

December 28, 2022

Mr. Paul McBarron

c/o Cyclacel Pharmaceuticals, Inc.

200 Connell Drive, Suite 1500

Berkeley Heights, NJ 07922

Dear Mr. McBarron:

Reference is made to the agreement between us (the “Agreement”) made as of January 1, 2021. This will confirm our agreement to extend the Agreement through the period ended June 30, 2023, effective as of January 1, 2023. Please confirm your agreement to the foregoing by signing below in the space provided.

	Sincerely,

	CYCLACEL PHARMACEUTICALS, INC.

	By:	/s/ Spiro Rombotis
	Name:	Spiro Rombotis
	Title:	President & CEO

ACKNOWLEDGED AND AGREED:

/s/ Paul McBarron
Paul McBarron